Mammograms may benefit women well into their 80s, UCLA study finds

Ben Ho Park, Sara Tolaney to receive awards at 2025 San Antonio Breast Cancer Symposium

Ben Ho ParkSara TolaneyBen Ho Park and Sara M. Tolaney will receive American Association for Cancer Research awards at the the San Antonio Breast Cancer Symposium Dec. 9-13 for their contributions to breast cancer research.

December 05, 2025

Vol.51 No.44

In Brief

UCLA Health launches Department of Nuclear Medicine and Theranostics

UCLA Health has established the Department of Nuclear Medicine and Theranostics—the first of its kind in the United States. The new department will integrate advanced imaging and therapy, accelerate scientific discovery, and advance precision health at UCLA Health.

November 21, 2025

Vol.51 No.43

Drugs & Targets

FDA approves Poherdy, first biosimilar to Perjeta, for breast cancer indication

FDA approved Poherdy (pertuzumab-dpzb) as an interchangeable biosimilar to Perjeta (pertuzumab). This is the first approval of a biosimilar for Perjeta.

November 21, 2025

Vol.51 No.43

In Brief

Paige Aiello joins Breast Cancer Multidisciplinary Team at Karmanos

Paige Aiello has joined The Barbara Ann Karmanos Cancer Institute as a breast surgeon and member of the Breast Cancer Multidisciplinary Team.

November 07, 2025

Vol.51 No.41

In Brief

Allen and Charlotte Ginsburg commit $31M to UCLA Research Park, David Geffen School of Medicine

UCLA Health has received a $31 million commitment from Allen and Charlotte Ginsburg and their research foundation to advance biomedical research at the UCLA Research Park.

November 07, 2025

Vol.51 No.41

Clinical Roundup

Enhertu reduced the risk of disease recurrence or death vs. T-DM1 in high-risk HER2+ early breast cancer following neoadjuvant therapy

Enhertu (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in invasive disease-free survival in patients with a high risk of disease recurrence, according to results from DESTINY-Breast05 phase III trial.

October 24, 2025

Vol.51 No.39

Mammograms may benefit women well into their 80s, UCLA study finds

YOU MAY BE INTERESTED IN

Ben Ho Park, Sara Tolaney to receive awards at 2025 San Antonio Breast Cancer Symposium

UCLA Health launches Department of Nuclear Medicine and Theranostics

FDA approves Poherdy, first biosimilar to Perjeta, for breast cancer indication

Paige Aiello joins Breast Cancer Multidisciplinary Team at Karmanos

Allen and Charlotte Ginsburg commit $31M to UCLA Research Park, David Geffen School of Medicine

Enhertu reduced the risk of disease recurrence or death vs. T-DM1 in high-risk HER2+ early breast cancer following neoadjuvant therapy

Renew today!

Subscriber content

Never miss an issue!

Login